8-41672338-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000037.4(ANK1):​c.5096+16T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.996 in 1,613,436 control chromosomes in the GnomAD database, including 799,783 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.98 ( 72868 hom., cov: 32)
Exomes 𝑓: 1.0 ( 726915 hom. )

Consequence

ANK1
NM_000037.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.169
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 8-41672338-A-G is Benign according to our data. Variant chr8-41672338-A-G is described in ClinVar as [Benign]. Clinvar id is 261315.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-41672338-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK1NM_000037.4 linkc.5096+16T>C intron_variant Intron 38 of 42 ENST00000289734.13 NP_000028.3 P16157-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK1ENST00000289734.13 linkc.5096+16T>C intron_variant Intron 38 of 42 1 NM_000037.4 ENSP00000289734.8 P16157-3

Frequencies

GnomAD3 genomes
AF:
0.978
AC:
148768
AN:
152166
Hom.:
72816
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.923
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.991
Gnomad ASJ
AF:
0.995
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.999
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.984
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.984
GnomAD2 exomes
AF:
0.993
AC:
247996
AN:
249630
AF XY:
0.995
show subpopulations
Gnomad AFR exome
AF:
0.923
Gnomad AMR exome
AF:
0.995
Gnomad ASJ exome
AF:
0.995
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
0.999
Gnomad OTH exome
AF:
0.995
GnomAD4 exome
AF:
0.997
AC:
1457383
AN:
1461150
Hom.:
726915
Cov.:
51
AF XY:
0.998
AC XY:
725257
AN XY:
726912
show subpopulations
African (AFR)
AF:
0.924
AC:
30928
AN:
33466
American (AMR)
AF:
0.994
AC:
44470
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.995
AC:
26004
AN:
26134
East Asian (EAS)
AF:
1.00
AC:
39693
AN:
39696
South Asian (SAS)
AF:
0.998
AC:
86081
AN:
86242
European-Finnish (FIN)
AF:
1.00
AC:
53045
AN:
53046
Middle Eastern (MID)
AF:
0.994
AC:
5735
AN:
5768
European-Non Finnish (NFE)
AF:
1.00
AC:
1111362
AN:
1111702
Other (OTH)
AF:
0.995
AC:
60065
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
195
390
586
781
976
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21660
43320
64980
86640
108300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.978
AC:
148880
AN:
152286
Hom.:
72868
Cov.:
32
AF XY:
0.979
AC XY:
72861
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.924
AC:
38380
AN:
41558
American (AMR)
AF:
0.991
AC:
15167
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.995
AC:
3456
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5162
AN:
5162
South Asian (SAS)
AF:
0.999
AC:
4817
AN:
4822
European-Finnish (FIN)
AF:
1.00
AC:
10618
AN:
10618
Middle Eastern (MID)
AF:
0.980
AC:
288
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68004
AN:
68034
Other (OTH)
AF:
0.984
AC:
2076
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
163
326
490
653
816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.981
Hom.:
8531
Bravo
AF:
0.975
Asia WGS
AF:
0.993
AC:
3455
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spherocytosis type 1 Benign:4
Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.40
DANN
Benign
0.27
PhyloP100
-0.17
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs508112; hg19: chr8-41529856; API